An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

564

HTML

4416

Figures (1-2)

604

Tables (1-3)

452

Sum=6036

Oct 6, 2010 (publication date) through Dec 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Pharmacol Ther. Oct 6, 2010; 1(5): 112-118
Published online Oct 6, 2010. doi: 10.4292/wjgpt.v1.i5.112

Figure 1 Chemical structure of Lafutidine[28].

Open in New Tab Full Size Figure Download Figure

Figure 2 Mean plasma concentration vs time curves of the test and reference tablets, each containing 10 mg lafutidine.

Citation: Dewan B, Chimata R. An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition. World J Gastrointest Pharmacol Ther 2010; 1(5): 112-118
URL: https://www.wjgnet.com/2150-5349/full/v1/i5/112.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v1.i5.112